ISPE

JULY 21, 2023

ICH Q9 (R1): The Next Frontier Trudy Patterson Fri, 07/21/2023 - 11:53 iSpeak Blog iSpeak ICH Q9 (R1): The Next Frontier Christopher John Potter, PhD 21 July 2023 A one-day seminar titled ICH Q9(R1): The Next Frontier was hosted by the Pharmaceutical Regulatory Science Team (PRST) at the Technological University Dublin (TU Dublin) on 1 June 2023.

Documentation 98

Documentation 98

Board Vitals - Pharmacist

APRIL 22, 2022

Events sponsored by an accredited CME provider include national, regional, or local conferences, workshops, seminars, journal clubs, simulation labs, and live webinars. This method is truly a type of self-directed learning in which you document a clinical question, the sources consulted, and the application to your practice. .

Documentation 52

Documentation 52

European Pharmaceutical Review

JUNE 29, 2022

A typical example is the classical biosafety animal testing driven by a collection of guidance documents that often were not revised for decades (eg, ICHQ 5A). However, the biosafety testing strategies rely on outdated technologies that have remained unchanged for decades. In vivo and in vitro tests were very powerful when first implemented.

Vaccines 85

Vaccines Documentation 85

ISPE

OCTOBER 28, 2022

It was usual practice for TGA to prepare additional guidance/explanatory documents for industry and for TGA inspection staff to participate in training seminars to assist industry.

FDA 97

FDA Vaccines Dosage Documentation 97

ISPE

NOVEMBER 21, 2022

It was usual practice for TGA to prepare additional guidance/explanatory documents for industry and for TGA inspection staff to participate in training seminars to assist industry.

FDA 52

FDA Vaccines Dosage Documentation 52

pharmaphorum

OCTOBER 20, 2020

Documenting the change in pharma’s engagement of HCPs is one thing – predicting where channel mix goes in the future, the most important question, is quite another. Preference shifts for the other two groupings, meetings events and seminars (in person or remote) and published medical content, see some, but much more minor, shifts.

Pharmaceutical Companies 120

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 120